系统性红斑狼疮患者抑郁与焦虑的患病率及测量工具:系统评价与荟萃分析
该系统评价与荟萃分析纳入72项研究,评估成人SLE患者抑郁和焦虑的患病率。抑郁合并患病率为35.0%(95%CI 29.9%-40.3%),焦虑为25.8%(95%CI 19.2%-32.9%)。不同测量工具下患病率差异较大,CES-D、BDI、HAM-D所得抑郁患病率相似,HADS-D最低。
要点
- 成人SLE患者抑郁合并患病率为35.0%,焦虑为25.8%。
- 不同测量工具下抑郁患病率差异明显,HADS-D最低(24.4%)。
- 各焦虑测量工具所得患病率相近,范围约38%-39%。
核心结论
- SLE患者抑郁和焦虑患病率较高,但不同研究间异质性大,抑郁范围8.7%-78.6%,焦虑范围1.1%-71.4%。
- 异质性可能源于测量工具及抑郁/焦虑定义的不一致。
- 使用CES-D、BDI或HAM-D的研究所得抑郁患病率相似,HADS-D最低;所有焦虑测量工具所得患病率相似。
研究设计与样本
- 遵循PRISMA指南的系统评价与荟萃分析,检索四个数据库(1954-2016年:Ovid Medline、Embase、PsycINFO和CINAHL)。
- 初检3103篇文献,226篇详细审阅,最终纳入72项研究。
- 抑郁合并患病率来自69项研究、23386例SLE患者;焦虑合并患病率来自38项研究、4439例SLE患者。
主要发现
- 抑郁合并患病率为35.0%(95%CI 29.9%-40.3%),焦虑合并患病率为25.8%(95%CI 19.2%-32.9%)。
- CES-D用于13项研究1856例患者,抑郁合并患病率41.5%(95%CI 35.1%-48.1%)。
- BDI用于14项研究1355例患者,抑郁合并患病率39.9%(95%CI 31.1%-49.1%);BAI用于3项研究489例患者,焦虑合并患病率38.4%(95%CI 34.2%-42.8%)。
- HADS-D用于14项研究1238例患者,抑郁合并患病率24.4%(95%CI 19.1%-30.1%);HADS-A用于12项研究1099例患者,焦虑合并患病率38.3%(95%CI 29.1%-47.9%)。
- HAM-D用于4项研究267例患者,抑郁合并患病率40.0%(95%CI 23.0%-59.0%);HAM-A用于4项研究213例患者,焦虑合并患病率39.0%(95%CI 32.0%-45.0%)。
关键数值与推荐
- 抑郁合并患病率35.0%(95%CI 29.9%-40.3%),基于69项研究23386例SLE患者。
- 焦虑合并患病率25.8%(95%CI 19.2%-32.9%),基于38项研究4439例SLE患者。
- CES-D抑郁合并患病率41.5%(95%CI 35.1%-48.1%),BDI抑郁合并患病率39.9%(95%CI 31.1%-49.1%),HADS-D抑郁合并患病率24.4%(95%CI 19.1%-30.1%),HAM-D抑郁合并患病率40.0%(95%CI 23.0%-59.0%)。
- BAI焦虑合并患病率38.4%(95%CI 34.2%-42.8%),HADS-A焦虑合并患病率38.3%(95%CI 29.1%-47.9%),HAM-A焦虑合并患病率39.0%(95%CI 32.0%-45.0%)。
临床怎么用
- 在SLE患者中应常规关注抑郁和焦虑,合并患病率分别约35%和26%。
- 解读患病率时需考虑测量工具差异,HADS-D所得抑郁患病率较低,CES-D、BDI、HAM-D所得相似。
- 焦虑评估在不同工具间结果相近,可依据临床可行性选择工具。
局限性
- 抑郁和焦虑患病率研究间异质性高(抑郁8.7%-78.6%,焦虑1.1%-71.4%)。
- 测量工具及抑郁/焦虑定义缺乏一致性,可能影响合并患病率。
- 部分测量工具的合并分析基于较少研究,如BAI仅3项研究、HAM-D/A各4项研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To systematically review and synthesize literature on 1) the overall prevalence of depression and anxiety in SLE patients in identified studies, and 2) the pooled prevalence per metrics of depression and anxiety in adult SLE patients. METHODS: This review used (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) PRISMA guidelines and in-depth searches in four databases (1954-2016; Ovid-based Medline, Embase, PsycINFO and CINAHL) to identify articles on the prevalence of depression and/or anxiety in adult SLE patients. Included studies were critically appraised and analyzed. The prevalence of depression and anxiety was studied for all included studies, and whenever possible, pooled prevalence (PP) was determined for more commonly used metrics. Statistical and publication bias was assessed using funnel plots. RESULT: A total of 3103 references were identified, 226 were selected for detailed review and 72 were included in the final analysis. OVERALL PREVALENCE: The depression PP, obtained from 69 studies representing 23,386 SLE patients, was 35.0% (95% CI: 29.9%-40.3%). The anxiety PP, obtained from 38 studies representing 4439 SLE patients, was 25.8% (95% CI: 19.2%-32.9%). PREVALENCE PER METRICS USED: The more commonly used instruments included the Centre for Epidemiological Studies - Depression (CES-D), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Hospital Anxiety and Depression Scales (HADS-A/D), and Hamilton Rating Scales for Depression/Anxiety (HAM-D/A)]. The CES-D was utilized in 13 studies including 1856 SLE patients; depression PP was 41.5% (95% CI: 35.1%-48.1%). The BDI was utilized in 14 studies including 1355 SLE patients and the BAI in 3 studies including 489 patients; depression PP was 39.9% (95% CI: 31.1%-49.1) and anxiety PP was 38.4% (95% CI: 34.2%-42.8%). The HADS-D was utilized in 14 studies including 1238 SLE patients and the HADS-A in 12 studies including 1099 patients respectively; its depression PP was 24.4% (95% CI: 19.1%-30.1%) and anxiety PP was 38.3% (95% CI: 29.1%-47.9%). The HAM-D was utilized in 4 studies including 267 SLE patients and the HAM-A in 4 studies including 213 patients respectively; its depression PP was 40.0% (95% CI: 23.0%-59.0%) and anxiety PP was 39.0% (95% CI: 32.0%-45.0%). CONCLUSION: There was high variability in the prevalence of depression and anxiety, ranging from 8.7%-78.6% and 1.1%-71.4%, respectively. This could be attributed to the lack of consistency in the metrics used and its definition for depression and anxiety in SLE. Studies that used a specific metric, such as the CES-D, BDI or HAM-D, yielded similar depression prevalence. The HADS-D had the lowest prevalence. All metrics of anxiety yielded similar anxiety prevalence.
引用
- Moustafa AT, Moazzami M, Engel L, et al. Prevalence and metric of depression and anxiety in systemic lupus erythematosus: A systematic review and meta-analysis. Semin Arthritis Rheum. 2019. PMID: 31303437. doi:10.1016/j.semarthrit.2019.06.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。